Analysis of the Activated Partial Thromboplastin Time Test Using Mathematical Modeling
Activated partial thromboplastin time (APTT) is a laboratory test for the diagnosis of blood coagulation disorders. The test consists of two stages: The first one is the preincubation of a plasma sample with negatively charged materials (kaolin, ellagic acid etc.) to activate factors XII and XI; the...
Gespeichert in:
Veröffentlicht in: | Thrombosis research 2001-02, Vol.101 (4), p.299-310 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 310 |
---|---|
container_issue | 4 |
container_start_page | 299 |
container_title | Thrombosis research |
container_volume | 101 |
creator | Kogan, Alexander E. Kardakov, Denis V. Khanin, Mikhail A. |
description | Activated partial thromboplastin time (APTT) is a laboratory test for the diagnosis of blood coagulation disorders. The test consists of two stages: The first one is the preincubation of a plasma sample with negatively charged materials (kaolin, ellagic acid etc.) to activate factors XII and XI; the second stage begins after the addition of calcium ions that triggers a chain of calcium-dependent enzymatic reactions resulting in fibrinogen clotting. Mathematical modeling was used for the analysis of the APTT test. The process of coagulation was described by a set of coupled differential equations that were solved by the numerical method. It was found that as little as 2.3×10
−9 μM of factor XIIa (1/10
000 of its plasma concentration) is enough to cause the complete activation of factor XII and prekallikrein (PK) during the first 20 s of the preincubation phase. By the end of this phase, kallikrein (K) is completely inhibited, residual activity of factor XIIa is 54%, and factor XI is activated by 26%. Once a clot is formed, factor II is activated by 4%, factor X by 5%, factor IX by 90%, and factor XI by 39%. Calculated clotting time using protein concentrations found in the blood of healthy people was 40.5 s. The most pronounced prolongation of APTT is caused by a decrease in factor X concentration. |
doi_str_mv | 10.1016/S0049-3848(00)00405-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76976197</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0049384800004059</els_id><sourcerecordid>76976197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-28e4271957f44e1d0e4cb42907765c387891bcab81fe348e9fae0d5cbc1e5fda3</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMotlZ_gpKT6GE12Wab5CSl-AUWBbdeQzY7ayP7UZO00H9v-oEePQ0Znndm8iB0TskNJXR0-04Ik8lQMHFFyHV8kCyRB6hPBZdJynh6iPq_SA-deP9FCOVUZseoR2nKRCppH32MW12vvfW4q3CYAx6bYFc6QInftAtW1zifu64pukWtfbAtzm0DOAcf8Mzb9hNPdYw1OlgT2WlXQh27p-io0rWHs30doNnDfT55Sl5eH58n45fEsJSHJBUQa7yJV4wBLQkwU7BUEs5HmRkKLiQtjC4ErWDIBMhKAykzUxgKWVXq4QBd7uYuXPe9jEepxnoDda1b6JZe8ZHkIyp5BLMdaFznvYNKLZxttFsrStRGqNoKVRtbihC1FapkzF3sFyyLBsq_1N5gBO52AMRvriw45Y2F1kBpHZigys7-s-IHTqGF5g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76976197</pqid></control><display><type>article</type><title>Analysis of the Activated Partial Thromboplastin Time Test Using Mathematical Modeling</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Kogan, Alexander E. ; Kardakov, Denis V. ; Khanin, Mikhail A.</creator><creatorcontrib>Kogan, Alexander E. ; Kardakov, Denis V. ; Khanin, Mikhail A.</creatorcontrib><description>Activated partial thromboplastin time (APTT) is a laboratory test for the diagnosis of blood coagulation disorders. The test consists of two stages: The first one is the preincubation of a plasma sample with negatively charged materials (kaolin, ellagic acid etc.) to activate factors XII and XI; the second stage begins after the addition of calcium ions that triggers a chain of calcium-dependent enzymatic reactions resulting in fibrinogen clotting. Mathematical modeling was used for the analysis of the APTT test. The process of coagulation was described by a set of coupled differential equations that were solved by the numerical method. It was found that as little as 2.3×10
−9 μM of factor XIIa (1/10
000 of its plasma concentration) is enough to cause the complete activation of factor XII and prekallikrein (PK) during the first 20 s of the preincubation phase. By the end of this phase, kallikrein (K) is completely inhibited, residual activity of factor XIIa is 54%, and factor XI is activated by 26%. Once a clot is formed, factor II is activated by 4%, factor X by 5%, factor IX by 90%, and factor XI by 39%. Calculated clotting time using protein concentrations found in the blood of healthy people was 40.5 s. The most pronounced prolongation of APTT is caused by a decrease in factor X concentration.</description><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/S0049-3848(00)00405-9</identifier><identifier>PMID: 11248291</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>APTT test ; Blood Coagulation Disorders - blood ; Blood Coagulation Disorders - diagnosis ; Blood Coagulation Factors - metabolism ; Contact activation ; Factor XIIa - metabolism ; Humans ; Kinetics ; Mathematical modeling ; Models, Biological ; Models, Theoretical ; Partial Thromboplastin Time</subject><ispartof>Thrombosis research, 2001-02, Vol.101 (4), p.299-310</ispartof><rights>2001 Elsevier Science Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427t-28e4271957f44e1d0e4cb42907765c387891bcab81fe348e9fae0d5cbc1e5fda3</citedby><cites>FETCH-LOGICAL-c427t-28e4271957f44e1d0e4cb42907765c387891bcab81fe348e9fae0d5cbc1e5fda3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0049384800004059$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11248291$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kogan, Alexander E.</creatorcontrib><creatorcontrib>Kardakov, Denis V.</creatorcontrib><creatorcontrib>Khanin, Mikhail A.</creatorcontrib><title>Analysis of the Activated Partial Thromboplastin Time Test Using Mathematical Modeling</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>Activated partial thromboplastin time (APTT) is a laboratory test for the diagnosis of blood coagulation disorders. The test consists of two stages: The first one is the preincubation of a plasma sample with negatively charged materials (kaolin, ellagic acid etc.) to activate factors XII and XI; the second stage begins after the addition of calcium ions that triggers a chain of calcium-dependent enzymatic reactions resulting in fibrinogen clotting. Mathematical modeling was used for the analysis of the APTT test. The process of coagulation was described by a set of coupled differential equations that were solved by the numerical method. It was found that as little as 2.3×10
−9 μM of factor XIIa (1/10
000 of its plasma concentration) is enough to cause the complete activation of factor XII and prekallikrein (PK) during the first 20 s of the preincubation phase. By the end of this phase, kallikrein (K) is completely inhibited, residual activity of factor XIIa is 54%, and factor XI is activated by 26%. Once a clot is formed, factor II is activated by 4%, factor X by 5%, factor IX by 90%, and factor XI by 39%. Calculated clotting time using protein concentrations found in the blood of healthy people was 40.5 s. The most pronounced prolongation of APTT is caused by a decrease in factor X concentration.</description><subject>APTT test</subject><subject>Blood Coagulation Disorders - blood</subject><subject>Blood Coagulation Disorders - diagnosis</subject><subject>Blood Coagulation Factors - metabolism</subject><subject>Contact activation</subject><subject>Factor XIIa - metabolism</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Mathematical modeling</subject><subject>Models, Biological</subject><subject>Models, Theoretical</subject><subject>Partial Thromboplastin Time</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQhoMotlZ_gpKT6GE12Wab5CSl-AUWBbdeQzY7ayP7UZO00H9v-oEePQ0Znndm8iB0TskNJXR0-04Ik8lQMHFFyHV8kCyRB6hPBZdJynh6iPq_SA-deP9FCOVUZseoR2nKRCppH32MW12vvfW4q3CYAx6bYFc6QInftAtW1zifu64pukWtfbAtzm0DOAcf8Mzb9hNPdYw1OlgT2WlXQh27p-io0rWHs30doNnDfT55Sl5eH58n45fEsJSHJBUQa7yJV4wBLQkwU7BUEs5HmRkKLiQtjC4ErWDIBMhKAykzUxgKWVXq4QBd7uYuXPe9jEepxnoDda1b6JZe8ZHkIyp5BLMdaFznvYNKLZxttFsrStRGqNoKVRtbihC1FapkzF3sFyyLBsq_1N5gBO52AMRvriw45Y2F1kBpHZigys7-s-IHTqGF5g</recordid><startdate>20010215</startdate><enddate>20010215</enddate><creator>Kogan, Alexander E.</creator><creator>Kardakov, Denis V.</creator><creator>Khanin, Mikhail A.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010215</creationdate><title>Analysis of the Activated Partial Thromboplastin Time Test Using Mathematical Modeling</title><author>Kogan, Alexander E. ; Kardakov, Denis V. ; Khanin, Mikhail A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-28e4271957f44e1d0e4cb42907765c387891bcab81fe348e9fae0d5cbc1e5fda3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>APTT test</topic><topic>Blood Coagulation Disorders - blood</topic><topic>Blood Coagulation Disorders - diagnosis</topic><topic>Blood Coagulation Factors - metabolism</topic><topic>Contact activation</topic><topic>Factor XIIa - metabolism</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Mathematical modeling</topic><topic>Models, Biological</topic><topic>Models, Theoretical</topic><topic>Partial Thromboplastin Time</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kogan, Alexander E.</creatorcontrib><creatorcontrib>Kardakov, Denis V.</creatorcontrib><creatorcontrib>Khanin, Mikhail A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kogan, Alexander E.</au><au>Kardakov, Denis V.</au><au>Khanin, Mikhail A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of the Activated Partial Thromboplastin Time Test Using Mathematical Modeling</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>2001-02-15</date><risdate>2001</risdate><volume>101</volume><issue>4</issue><spage>299</spage><epage>310</epage><pages>299-310</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><abstract>Activated partial thromboplastin time (APTT) is a laboratory test for the diagnosis of blood coagulation disorders. The test consists of two stages: The first one is the preincubation of a plasma sample with negatively charged materials (kaolin, ellagic acid etc.) to activate factors XII and XI; the second stage begins after the addition of calcium ions that triggers a chain of calcium-dependent enzymatic reactions resulting in fibrinogen clotting. Mathematical modeling was used for the analysis of the APTT test. The process of coagulation was described by a set of coupled differential equations that were solved by the numerical method. It was found that as little as 2.3×10
−9 μM of factor XIIa (1/10
000 of its plasma concentration) is enough to cause the complete activation of factor XII and prekallikrein (PK) during the first 20 s of the preincubation phase. By the end of this phase, kallikrein (K) is completely inhibited, residual activity of factor XIIa is 54%, and factor XI is activated by 26%. Once a clot is formed, factor II is activated by 4%, factor X by 5%, factor IX by 90%, and factor XI by 39%. Calculated clotting time using protein concentrations found in the blood of healthy people was 40.5 s. The most pronounced prolongation of APTT is caused by a decrease in factor X concentration.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>11248291</pmid><doi>10.1016/S0049-3848(00)00405-9</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0049-3848 |
ispartof | Thrombosis research, 2001-02, Vol.101 (4), p.299-310 |
issn | 0049-3848 1879-2472 |
language | eng |
recordid | cdi_proquest_miscellaneous_76976197 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | APTT test Blood Coagulation Disorders - blood Blood Coagulation Disorders - diagnosis Blood Coagulation Factors - metabolism Contact activation Factor XIIa - metabolism Humans Kinetics Mathematical modeling Models, Biological Models, Theoretical Partial Thromboplastin Time |
title | Analysis of the Activated Partial Thromboplastin Time Test Using Mathematical Modeling |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T21%3A30%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20the%20Activated%20Partial%20Thromboplastin%20Time%20Test%20Using%20Mathematical%20Modeling&rft.jtitle=Thrombosis%20research&rft.au=Kogan,%20Alexander%20E.&rft.date=2001-02-15&rft.volume=101&rft.issue=4&rft.spage=299&rft.epage=310&rft.pages=299-310&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/S0049-3848(00)00405-9&rft_dat=%3Cproquest_cross%3E76976197%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76976197&rft_id=info:pmid/11248291&rft_els_id=S0049384800004059&rfr_iscdi=true |